| scholarly article | Q13442814 |
| P2093 | author name string | Emine Zengin | |
| Nazan Sarper | |||
| Suar Cakı Kılıç | |||
| P2860 | cites work | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 | ||
| Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification | Q36071289 | ||
| Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis | Q37244986 | ||
| Etiology and clinical course of febrile neutropenia in children with cancer | Q37344556 | ||
| Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey | Q40177437 | ||
| Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases | Q40285545 | ||
| Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients | Q40393011 | ||
| Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison | Q40484723 | ||
| Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study | Q40497134 | ||
| Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols | Q40508687 | ||
| Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost | Q40512932 | ||
| Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children | Q40533384 | ||
| Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children | Q40534069 | ||
| Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis | Q40585149 | ||
| Infection risk factors in febrile, neutropenic children and adolescents | Q40669044 | ||
| P433 | issue | 4 | |
| P921 | main subject | amikacin | Q408529 |
| piperacillin/tazobactam | Q7197337 | ||
| P304 | page(s) | 311-320 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Pediatric Hematology and Oncology | Q7159205 |
| P1476 | title | Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia | |
| P478 | volume | 28 |
| Q24201767 | Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia |
| Q38160639 | Neutrophil gelatinase associated lipocalin in acute kidney injury |
| Q90549710 | Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies |
Search more.